Reply to: Potential of 188Re as an alternative to 177Lu and dosimetric consequences: letters to the editor

REPLY: In our recent publication about the preclinical development and clinical translation of 99mTc- and 188Re-PSMA-GCK01, we consciously withheld the presentation of dosimetry estimates, despite having serial planar images of patients available ([1][1]). One reason is the limited quantitative

Saved in:
Bibliographic Details
Main Authors: Cardinale, Jens (Author) , Giesel, Frederik L. (Author) , Wensky, Christina (Author) , Rathke, Hendrik (Author) , Haberkorn, Uwe (Author) , Kratochwil, Clemens (Author)
Format: Article (Journal) Editorial
Language:English
Published: Aug. 3, 2023
In: Journal of nuclear medicine
Year: 2023, Volume: 64, Issue: 10, Pages: 1663-1664
ISSN:0097-9058
DOI:10.2967/jnumed.123.266195
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.2967/jnumed.123.266195
Verlag, lizenzpflichtig, Volltext: https://jnm.snmjournals.org/content/64/10/1663.2
Get full text
Author Notes:Jens Cardinale, Frederik L. Giesel, Christina Wensky, Hendrik G. Rathke, Uwe Haberkorn, Clemens Kratochwil
Description
Summary:REPLY: In our recent publication about the preclinical development and clinical translation of 99mTc- and 188Re-PSMA-GCK01, we consciously withheld the presentation of dosimetry estimates, despite having serial planar images of patients available ([1][1]). One reason is the limited quantitative
Item Description:Im Titel sind die Zahlen "188" und "177" hochgestellt
Gesehen am 28.01.2025
Physical Description:Online Resource
ISSN:0097-9058
DOI:10.2967/jnumed.123.266195